Herbs and dietary supplement use in patients with stage 5 chronic kidney disease

被引:0
|
作者
Burrowes, Jerrilynn D.
Van Houten, Gloria
机构
[1] Long Isl Univ, Dept Nutr, Sch Hlth Profess & Nursing, Brookville, NY 11545 USA
[2] St Catherine Siena Med Ctr, Ctr Renal Dis, Smithtown, NY USA
关键词
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Herbal products and dietary supplements are complementary and alternative medicine (CAM) therapies that have grown faster than any other CAM treatments. Little information is available about the use of these products in the stage 5 chronic kidney disease (CKD) population. Information on the use, safety, efficacy, adverse effects, and recommended dosages in the nondialysis population are summarized in this article.
引用
收藏
页码:85 / 88
页数:4
相关论文
共 50 条
  • [41] Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements
    Mayuree Tangkiatkumjai
    Helen Boardman
    Kearkiat Praditpornsilpa
    Dawn-Marie Walker
    [J]. BMC Complementary and Alternative Medicine, 14
  • [42] EFFECT OF TOLVAPTAN IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE G5 AND IMPACT OF CONCOMITANT USE OF THIAZIDE DIURETICS
    Uchiyama, Kiyotaka
    Kojima, Daiki
    Hama, Eriko Yoshida
    Nagasaka, Tomoki
    Nakayama, Takashin
    Takahashi, Rina
    Tajima, Takaya
    Morimoto, Kohkichi
    Washida, Naoki
    Itoh, Hiroshi
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 : E386 - E386
  • [43] Combined use of handgrip strength and hemoglobin as markers of undernutrition in patients with stage 3-5 chronic kidney disease
    Lonardo, Maria Serena
    Cacciapuoti, Nunzia
    Chiurazzi, Martina
    Di Lauro, Mariastella
    Guida, Bruna
    Damiano, Simona
    Cataldi, Mauro
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (11) : 2169 - 2178
  • [44] Dietary Supplement Use in Live Kidney Donors and Recipients
    Persun, Nicole
    Johnson, David
    Leonberg-Yoo, Amanda
    Bahrainwala, Jehan
    Reese-, Peter P.
    Steiner, Brendan
    Witmer, Brooke
    Rashid, Jamal
    Naji, Ali
    Trofe-Clark, Jennifer
    [J]. TRANSPLANT RESEARCH AND RISK MANAGEMENT, 2020, 12 : 9 - 14
  • [45] Hepatitis B vaccination in patients with stage 4/5 chronic kidney disease - a review
    Light, Casey
    Heslop, Karen
    Kulkarni, Hemant
    [J]. RENAL SOCIETY OF AUSTRALASIA JOURNAL, 2023, 19 (02) : 68 - 76
  • [46] Hip fracture in patients with non-dialysis chronic kidney disease stage 5
    Tang, Chao-Hsiun
    Chou, Che-Yi
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] Semaglutide Tolerability and Efficacy in Patients with Chronic Kidney Disease Stage 4, 5 and End Stage Renal Disease.
    Long, J. J.
    Lemke, A.
    Sudhindran, V.
    Pencovici, N.
    Kukla, A.
    Diwan, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 685 - 685
  • [48] A PILOT STUDY OF PHARMACOGENOMICS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5 OF UNCERTAIN CAUSE
    Chung, Y. L.
    Patel, C.
    Mallawaarachchi, A.
    Stark, Z.
    Simons, C.
    Quinlan, C.
    Mallett, A.
    [J]. NEPHROLOGY, 2020, 25 : 63 - 63
  • [49] Decreased Bioimpedance Phase Angle in Patients with Diabetic Chronic Kidney Disease Stage 5
    Han, Byoung-Geun
    Lee, Jun Young
    Kim, Jae-Seok
    Yang, Jae-Won
    [J]. NUTRIENTS, 2019, 11 (12)
  • [50] Bone mineral disturbances in patients with chronic kidney disease stage 5 not yet on dialysis
    Pernat, Andreja Marn
    Zrimsek, Matej
    [J]. CLINICAL NEPHROLOGY, 2017, 88 : S39 - S43